Phone: 1-800-226-2379

Second and Third Years

Research Training

The Pediatric Hematology-Oncology Training Program emphasizes the importance of achieving significant research expertise and productivity during fellowship training. A strong foundation in research is critically important to the development of a successful academic career.

The fellow’s formal education in research includes an Orientation to Research curriculum and courses at the Baylor College of Medicine in the Fundamentals of Clinical Investigation and Responsible Conduct of Research at the start of the second year of fellowship. These courses introduce the fellow to the concepts of research design, data analysis, ethics of research, as well as practical guidance to successfully transitioning to the research environment.

Beginning with the initial orientation month and continuing throughout the fellowship, trainees learn about clinical research through their exposure and involvement in numerous ongoing clinical trials and study protocols. Our physicians develop trials and participate in all major pediatric cancer and blood disorder cooperative clinical trial groups, like the Children’s Oncology Group (COG) and the Pediatric Brain Tumor Consortium (PBTC).

During weekly teaching conferences, fellows are exposed to the presentation and interpretation of research data by clinical researchers and laboratory investigators. At the weekly Research Seminars, faculty and visiting speakers present and discuss their research. Visiting speakers often meet with the fellows in lunchtime discussion sessions. Beginning in late fall of their first year, trainees attend a series of special presentations given by laboratory and clinical research-oriented investigators. These sessions are designed to familiarize the fellows with specific research conducted throughout the Program’s many laboratories. Physicians and scientists in the 47 laboratories of the Cancer and Hematology Centers perform research in molecular oncology, precision oncology, immunotherapy, cancer genetics, cancer genomics, cell and gene therapy, pharmacology and experimental therapeutics, neuro-oncology, tumor immunology, transplantation and stem cell biology, and hematology. Learn more about our research areas in hematology/oncology.

During the subsequent two to three months, fellows make individual appointments with selected faculty members of their choice to discuss future research opportunities. Fellows may also explore research opportunities within other research groups and laboratories throughout BCM and the Texas Medical Center. By the end of May of their first year, with guidance from their clinical mentor, Section Chief, and the fellowship leadership, each fellow selects a research mentor and laboratory or clinical research project.

Subsequently, during the second and third years of fellowship, the fellows have protected time with limited clinical responsibilities in order to focus on their independent research project under the supervision of their research mentor. Fellows commit approximately 80% of their time to their research projects. The goal of training during this period is for the fellow to develop the research skills and training necessary to ultimately become a successful independent laboratory or clinical investigator. Fellows pursuing an academic research pathway are encouraged to continue their research during their fourth year.

Excellent mentorship is a hallmark of our fellowship training program. Fellows receive individualized in-depth training in their selected clinical or basic research interest under the mentorship of a committed faculty research mentor. These research mentors are dedicated to ensuring that each fellow receives the guidance and direction necessary to develop a successful career in academic Pediatric Hematology-Oncology. Fellows are responsible for carrying out an independent research project. They receive support from their Scholarship Oversight Committee, a faculty advisory committee which is personalized for each fellow to include the fellow’s research mentor and additional faculty members with expertise in the fellow’s area of research and convenes formally with the fellow to ensure a productive and successful research experience.

Continuing Clinical Training in Second and Third Years

In order to maintain and enhance fellows’ clinical skills during this extended research period, all fellows’ continue to have clinical responsibilities which account for approximately 20% of their time. Fellows spend a half-day per week in their continuity clinic, in addition to some night and weekend coverage responsibilities. They also spend one month on the inpatient Bone Marrow Transplantation service during their second year of fellowship. Overall, throughout the 36-month fellowship program, the trainees spend approximately 50% of their time in various clinical settings and the remaining 50% engaged in research activities.

In addition, fellows continue to participate in the ongoing schedule of educational conferences and research seminars, all of which serve to enhance their educational experience.

Videos

  • Embedded thumbnail for Texas Children’s Cancer Center®: a premiere center for pediatric oncology
    Texas Children’s Cancer Center®: a premiere center for pediatric oncology
  • Embedded thumbnail for Neuroblastoma Program at Texas Children’s Cancer Center®
    Neuroblastoma Program at Texas Children’s Cancer Center®
  • Embedded thumbnail for Medically Speaking: Heavy Menstrual Bleeding & Bleeding Disorders
    Medically Speaking: Heavy Menstrual Bleeding & Bleeding Disorders
  • Embedded thumbnail for Medically Speaking: Treatment Advances in Sickle Cell Disease, Amber M. Yates, MD
    Medically Speaking: Treatment Advances in Sickle Cell Disease, Amber M. Yates, MD
  • Embedded thumbnail for Celebration of Champions
    Celebration of Champions
  • Embedded thumbnail for Texas Children’s Goes Gold
    Texas Children’s Goes Gold
  • Embedded thumbnail for Kaylee’s Journey: Overcoming Ovarian Cancer
    Kaylee’s Journey: Overcoming Ovarian Cancer
  • Embedded thumbnail for Tucker’s Journey: Fighting Back Against Wilms’ Tumor
    Tucker’s Journey: Fighting Back Against Wilms’ Tumor
  • Embedded thumbnail for Medically Speaking: Precision Medicine, Will Parsons, MD
    Medically Speaking: Precision Medicine, Will Parsons, MD
  • Embedded thumbnail for Medically Speaking: Iron Deficiency, Jacquelyn M. Powers, MD, MS
    Medically Speaking: Iron Deficiency, Jacquelyn M. Powers, MD, MS
  • Embedded thumbnail for Medically Speaking: Cancer Clinical Trials, Stacey L. Berg, MD
    Medically Speaking: Cancer Clinical Trials, Stacey L. Berg, MD
  • Embedded thumbnail for Liver Tumor Program at Texas Children's Cancer Center
    Liver Tumor Program at Texas Children's Cancer Center
  • Embedded thumbnail for Shauntelle’s Story: Traveling Across the Globe for Histiocytosis Treatment at Texas Children’s
    Shauntelle’s Story: Traveling Across the Globe for Histiocytosis Treatment at Texas Children’s
  • Embedded thumbnail for The Future of Osteosarcoma and Other Pediatric Bone Tumors
    The Future of Osteosarcoma and Other Pediatric Bone Tumors
  • Embedded thumbnail for Conrad’s Story: Brain Tumor Program at Texas Children’s Hospital
    Conrad’s Story: Brain Tumor Program at Texas Children’s Hospital
  • Embedded thumbnail for TARE procedure available for pediatric liver cancer patients at Texas Children's Hospital
    TARE procedure available for pediatric liver cancer patients at Texas Children's Hospital
  • Embedded thumbnail for The Vannie Cook Clinic, Texas Children’s Cancer Center® in the Rio Grande Valley
    The Vannie Cook Clinic, Texas Children’s Cancer Center® in the Rio Grande Valley
  • Embedded thumbnail for  Vannie Cook Children’s Clinic: Hear from our patients
    Vannie Cook Children’s Clinic: Hear from our patients
  • Embedded thumbnail for Not all superheroes wear capes. This month, they do.
    Not all superheroes wear capes. This month, they do.
  • Embedded thumbnail for A glimpse into Texas Children’s Cancer Center®
    A glimpse into Texas Children’s Cancer Center®
  • Embedded thumbnail for Texas Children's Global HOPE
    Texas Children's Global HOPE
  • Embedded thumbnail for MIBG Treatment at Texas Children’s Cancer Center
    MIBG Treatment at Texas Children’s Cancer Center
  • Embedded thumbnail for World Sickle Cell Day event
    World Sickle Cell Day event
  • Embedded thumbnail for Going Gold at Texas Children's Cancer Center
    Going Gold at Texas Children's Cancer Center
  • Embedded thumbnail for Eden’s Journey: Surviving and Thriving After Battling a Rare Tumor
    Eden’s Journey: Surviving and Thriving After Battling a Rare Tumor
  • Embedded thumbnail for Results of glioblastoma clinical trial show safety and clinical benefit of CAR T cell therapy
    Results of glioblastoma clinical trial show safety and clinical benefit of CAR T cell therapy
  • Embedded thumbnail for  Creating Global HOPE: Addressing Pediatric Cancer in Africa
    Creating Global HOPE: Addressing Pediatric Cancer in Africa
  • Embedded thumbnail for Surgical Oncology at Texas Children’s Hospital
    Surgical Oncology at Texas Children’s Hospital
  • Embedded thumbnail for Texas Children's Cancer Center: The Largest Pediatric Cancer And Blood Disorders Center In The U.S.
    Texas Children's Cancer Center: The Largest Pediatric Cancer And Blood Disorders Center In The U.S.
  • Embedded thumbnail for Behind the U.S.News & World Report Rankings: Cancer Center
    Behind the U.S.News & World Report Rankings: Cancer Center
  • Embedded thumbnail for  Asa’s Liver Cancer Survival Story: Beating Hepatoblastoma at Texas Children’s
    Asa’s Liver Cancer Survival Story: Beating Hepatoblastoma at Texas Children’s
  • Embedded thumbnail for Histiocytosis: A Comprehensive Overview with Texas Children’s Cancer Center
    Histiocytosis: A Comprehensive Overview with Texas Children’s Cancer Center
  • Embedded thumbnail for Texas Children's Cancer Center: Jacob's Story
    Texas Children's Cancer Center: Jacob's Story
  • Embedded thumbnail for Precision Oncology: Changing the Future of Pediatric Cancer Treatment
    Precision Oncology: Changing the Future of Pediatric Cancer Treatment